Collaborate with NEALS
The NEALS Consortium has over 150 trial-ready sites with more than 1,000 individual members, two integrated coordination centers, extensive shared clinical data and biofluid samples, and a long history of conducting high-quality studies.
NEALS Scientific Advisory Board
An experienced Scientific Advisory Board and Executive Committee advises NEALS research activities. Each member brings a depth of experience and a unique perspective to the governance of NEALS.
The NEALS SAB is available to meet with investigators to advise on clinical and pre-clinical projects:
- Provides a forum for investigators and industry to evaluate new ideas for drugs, technologies and trials
Welcomes presentations from industry, NEALS members, and academic partners during scheduled teleconferences
- Offers confidential feedback from seasoned ALS scientists and trialists
Any meeting with the NEALS SAB will be structured as such:
- 45 minutes for company presentation and discussion with the NEALS Science Advisory Board
- 15 minutes for internal/off-line discussion amongst the NEALS SAB members to try to answer the questions raised in the presentation.
NEALS can offer a group CDA that includes members of the NEALS Leadership team, and the presentation will remain confidential. Additionally, there will be an opportunity for follow-up discussions after the meeting.
A nominal affiliated meeting fee includes the initial meeting, the SAB’s review, and a short, written response after the meeting. These fees are used to support ongoing NEALS infrastructure activities and do not directly compensate any individual member(s) of the NEALS Science Advisory Board. There is no meeting fee for NEALS members/academics.
NEALS Affiliated Trials
The NEALS Consortium is an active network of trial-ready sites with extensive experience in designing and managing FDA-regulated clinical trials for ALS. Governed by a seasoned Leadership Team, NEALS has successfully partnered with industry and academic researchers to conduct high-quality ALS studies for over 25 years and has grown to be the largest ALS research consortium in the world.
Recruitment and retention across NEALS-affiliated studies have been consistently excellent, and NEALS has pioneered a number of innovations aimed at improving clinical trial efficiency. The members of NEALS are actively engaged in a range of ALS clinical research studies, including clinical trials and observational studies
Becoming a NEALS-Affiliated Trial can include support for mechanisms such as:
- Webinars for both people living with ALS and trial sites
Sharing study information with the NEALS membership through emails, announcements, and website content
- Emails to NEALS Investigators
Engagement with NEALS Committees
- Investigator meeting at the Annual NEALS Meeting
- Site Selection including recommendations from the NEALS Site Selection Committee for trial sites
- Community Engagement this includes interactions with RAs, support creating PABs, etc.
NEALS welcomes the opportunity to partner on projects and encourages those interested in learning more to reach out to Carly Allen (NEALS Program Director) at email hidden; JavaScript is required.